Retour
28
Fourchette du Jour
175,83 €
183,83 €
Fourchette 52 Semaines
168,14 €
310,50 €
Volume
1 310 999
Moyenne 50J / 200J
196,45 €
/
254,18 €
Clôture Précédente
179,11 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 32,2 | 0,2 |
| P/B | 4,1 | 3,0 |
| ROE % | 13,9 | 3,6 |
| Net Margin % | 28,4 | 3,8 |
| Rev Growth 5Y % | 14,6 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
280,10 €
+57.3%
Low: 205,00 €
High: 333,00 €
P/E Prévisionnel
22,43
BPA Prévisionnel
7,94 €
Croissance BPA (est.)
+0,0%
CA Est.
3,17B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2031 |
15,30 €
15,08 € – 15,62 €
|
5,88B | 2 |
| FY2030 |
13,17 €
12,98 € – 13,44 €
|
5,17B | 1 |
| FY2029 |
11,15 €
9,77 € – 12,65 €
|
4,54B | 5 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-04 | N/A | 1,45 € | — |
| 2025-11-20 | 1,95 € | 2,04 € | +4,6% |
| 2025-08-27 | 1,90 € | 1,99 € | +4,7% |
| 2025-03-05 | 1,60 € | 1,74 € | +8,8% |
| 2024-12-05 | 1,58 € | 1,75 € | +10,8% |
| 2024-08-28 | 1,53 € | 1,62 € | +5,9% |
| 2024-05-30 | 1,42 € | 1,50 € | +5,6% |
| 2024-02-29 | 1,30 € | 1,38 € | +6,2% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 14,63% annually over 5 years — strong growth
Earnings grew 27,27% over the past year
ROE of 13,93% — decent returns on equity
Net margin of 28,44% shows strong profitability
Debt/Equity of 0,01 — conservative balance sheet
Generating 1,39B in free cash flow
Croissance
Revenue Growth (5Y)
14,63%
Revenue (1Y)16,34%
Earnings (1Y)27,27%
FCF Growth (3Y)25,14%
Qualité
Return on Equity
13,93%
ROIC9,40%
Net Margin28,44%
Op. Margin28,68%
Sécurité
Debt / Equity
0,01
Current Ratio4,89
Interest Coverage0,00
Valorisation
P/E Ratio
32,21
Forward P/E22,43
P/B Ratio4,06
EV/EBITDA30,50
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16,34% | Revenue Growth (3Y) | 16,27% |
| Earnings Growth (1Y) | 27,27% | Earnings Growth (3Y) | 31,49% |
| Revenue Growth (5Y) | 14,63% | Earnings Growth (5Y) | 20,76% |
| Profitability | |||
| Revenue (TTM) | 3,20B | Net Income (TTM) | 908,91M |
| ROE | 13,93% | ROA | 10,12% |
| Gross Margin | 75,53% | Operating Margin | 28,68% |
| Net Margin | 28,44% | Free Cash Flow (TTM) | 1,39B |
| ROIC | 9,40% | FCF Growth (3Y) | 25,14% |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 4,89 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 32,21 | Forward P/E | 22,43 |
| P/B Ratio | 4,06 | P/S Ratio | 9,16 |
| PEG Ratio | 1,42 | Forward PEG | N/A |
| EV/EBITDA | 30,50 | Fwd EV/EBITDA | 34,91 |
| Forward P/S | 9,23 | Fwd Earnings Yield | 4,46% |
| FCF Yield | 4,74% | ||
| Market Cap | 29,27B | Enterprise Value | 27,95B |
Income Statement
Annual, most recent first
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 3,20B | 2,75B | 2,36B | 2,16B | 1,85B |
| Net Income | 908,91M | 714,14M | 525,71M | 487,71M | 427,39M |
| EPS (Diluted) | 5,44 | 4,32 | 3,22 | 3,00 | 2,63 |
| Gross Profit | 2,41B | 2,05B | 1,69B | 1,55B | 1,35B |
| Operating Income | 916,37M | 691,44M | 429,33M | 459,09M | 505,50M |
Balance Sheet
Annual, most recent first
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Total Assets | 8,98B | 7,34B | 5,91B | 4,80B | 3,82B |
| Total Liabilities | 1,76B | 1,51B | 1,27B | 1,09B | 904,83M |
| Shareholders' Equity | 7,21B | 5,83B | 4,64B | 3,72B | 2,91B |
| Total Debt | 95,86M | 75,78M | 55,78M | 60,98M | 54,59M |
| Cash & Equivalents | 1,42B | 1,12B | 703,49M | 886,47M | 1,14B |
| Current Assets | 8,00B | 6,31B | 5,00B | 3,97B | 3,11B |
| Current Liabilities | 1,64B | 1,40B | 1,18B | 1,01B | 840,78M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#860 of 1049
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026